Related references
Note: Only part of the references are listed.Paediatric-onset hereditary spastic paraplegias: a retrospective cohort study
Silvia Schiavoni et al.
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY (2020)
Is NIPA1-associated hereditary spastic paraplegia always 'pure'? Further evidence of motor neurone disease and epilepsy as rare manifestations
Matthew Tanti et al.
NEUROGENETICS (2020)
Increased Diagnostic Yield of Spastic Paraplegia with or Without Cerebellar Ataxia Through Whole-Genome Sequencing
Aryun Kim et al.
CEREBELLUM (2019)
Genetic and Clinical Profile of Chinese Patients with Autosomal Dominant Spastic Paraplegia
Miao Zhao et al.
MOLECULAR DIAGNOSIS & THERAPY (2019)
Genetic background of the hereditary spastic paraplegia phenotypes in Hungary - An analysis of 58 probands
Peter Balicza et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2016)
Recurrent de novo c.316G>A mutation in NIPA1 hotspot
Peter Hedera
JOURNAL OF THE NEUROLOGICAL SCIENCES (2013)
TDP-43 pathology in a case of hereditary spastic paraplegia with a NIPA1/SPG6 mutation
Maria Martinez-Lage et al.
ACTA NEUROPATHOLOGICA (2012)
Hereditary spastic paraplegias with autosomal dominant, recessive, X-linked, or maternal trait of inheritance
Josef Finsterer et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2012)
Expansion of the phenotypic spectrum of SPG6 caused by mutation in NIPA1
Juan Du et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2011)
NIPA1 mutation in complex hereditary spastic paraplegia with epilepsy
K. Svenstrup et al.
EUROPEAN JOURNAL OF NEUROLOGY (2011)
The effect of HSP-causing mutations in SPG3A and NIPA1 on the assembly, trafficking, and interaction between atlastin-1 and NIPA1
Emmanuel J. Botzolakis et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2011)
Recurrent microdeletions at 15q11.2 and 16p13.11 predispose to idiopathic generalized epilepsies
Carolien G. F. de Kovel et al.
BRAIN (2010)
The hereditary spastic paraplegia proteins NIPA1, spastin and spartin are inhibitors of mammalian BMP signalling
Hilda T. H. Tsang et al.
HUMAN MOLECULAR GENETICS (2009)
Screening of hereditary spastic paraplegia patients for alterations at NIPA1 mutational hotspots
Christian Beetz et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2008)
NIPA1(SPG6), the basis for autosomal dominant form of hereditary spastic paraplegia, encodes a functional Mg2+ transporter
Angela Goytain et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
NIPA1 (SPG6) mutations are a rare cause of autosomal dominant spastic paraplegia in Europe
Stephan Klebe et al.
NEUROGENETICS (2007)
Novel SPG6 mutation p.A100T in a Japanese family with autosomal dominant form of hereditary spastic paraplegia
Satoshi Kaneko et al.
MOVEMENT DISORDERS (2006)
Clinical and genetic study of a Brazilian family with spastic paraplegia (SPG6 locus)
RP Munhoz et al.
MOVEMENT DISORDERS (2006)
A novel NIPA1 mutation associated with a pure form of autosomal dominant hereditary spastic paraplegia
JA Reed et al.
NEUROGENETICS (2005)
Distinct novel mutations affecting the same base in the NIPA1 gene cause autosomal dominant hereditary spastic paraplegia in two Chinese families
SQ Chen et al.
HUMAN MUTATION (2005)
NIPA1 gene mutations cause autosomal dominant hereditary spastic paraplegia (SPG6)
S Rainier et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2003)